G. Fossati

发表

Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytes.

R. Supino, G. Parmiani, C. Gambacorti-Passerini, 1988, Cancer research.

Lysis by activated lymphocytes of melanoma and small cell lung cancer cells surviving in vitro treatment with mafosfamide.

E. Erba, G. Parmiani, C. Gambacorti-Passerini, 1987, Cancer research.

Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cells

D. Taramelli, N. Cascinelli, A. Anichini, 2004, Cancer and Metastasis Reviews.

Melanoma cell lysis by human CTL clones: Differential involvement of T3, T8 and HLA antigens

A. Anichini, G. Parmiani, G. Fossati, 1987, International journal of cancer.

Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction.

A. Anichini, G. Parmiani, A. Mazzocchi, 1989, Journal of immunology.

Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.

G. Sozzi, A. Anichini, G. Parmiani, 1987, Journal of immunology.

Cellular and humoral immunity against human malignant melanoma

N. Cascinelli, M. Colnaghi, G. Fossati, 1971, International journal of cancer.

Clonal analysis of cytotoxic T‐lymphocyte response to autologous human metastatic melanoma

A. Anichini, G. Parmiani, G. Fossati, 1985, International journal of cancer.

Adoptive immunotherapy of cancer with immune and activated lymphocytes: Experimental and clinical studies

M. Colombo, N. Cascinelli, L. Grazioli, 1986, La Ricerca in clinica e in laboratorio.

Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon γ

A. Anichini, G. Parmiani, R. Mortarini, 1986, International journal of cancer.

Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.

D. Taramelli, D. Delia, S. Ferrone, 1986, Cancer research.

HLA Class II Antigens on Melanoma Cells

A. Anichini, G. Parmiani, C. Castelli, 1990 .

Immune response to autologous human melanoma: implication of class I and II MHC products.

J. Kirkwood, D. Taramelli, A. Anichini, 1986, Biochimica et biophysica acta.

Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells

G. Parmiani, C. Gambacorti-Passerini, M. Radrizzani, 2004, Cancer Immunology, Immunotherapy.

Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.

S. Ménard, S. Canevari, E. Tagliabue, 1983, Cancer research.

Potential therapeutic use of autologous human lymphocytes in metastatic melanoma: in vivo interleukin 2-activated peripheral blood lymphocytes and in vitro activated peripheral blood and tumor-infiltrating lymphocytes.

N. Cascinelli, G. Parmiani, C. Gambacorti-Passerini, 1988, Advances in experimental medicine and biology.

Lack of suppressive activity of human primary melanoma cells on the activation of autologous lymphocytes

D. Taramelli, G. Parmiani, A. Mazzocchi, 2004, Cancer Immunology, Immunotherapy.

Loss of Heterozygosity of Dq Alpha Gene in Human Malignant Melanoma

G. Parmiani, C. Castelli, M. Sensi, 1989, Tumori.

LOSS OF POLYMORPHIC RESTRICTION FRAGMENTS OF CLASS I AND CLASS II MHC GENES IN A MALIGNANT MELANOMA

G. Ferrara, P. Radice, M. Pierotti, 1986, Journal of immunogenetics.

Reactivity of human lymphocyte clones to autologous metastatic melanoma cells.

A. Anichini, G. Parmiani, A. Mazzocchi, 1988, Advances in experimental medicine and biology.

Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma.

D. Taramelli, D. Delia, G. Parmiani, 1985, British Journal of Cancer.

Proliferative and/or cytotoxic activity of lymphocyte clones to autologous human melanoma

A. Anichini, G. Parmiani, A. Mazzocchi, 1988, International journal of cancer.

Clonal analysis of the cytolytic T-cell response to human tumors.

A. Anichini, G. Parmiani, G. Fossati, 1987, Immunology today.

Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy?

A. Anichini, G. Parmiani, G. Fossati, 1990, Journal of the National Cancer Institute.

Induction of autologous human melanoma killer lymphocytes by allostimulation

G. Parmiani, G. Fossati, 1985 .

The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA‐DR antigens on the tumor cells

D. Taramelli, G. Parmiani, A. Balsari, 1984, International journal of cancer.

Primary but not metastatic human melanomas expressing dr antigens stimulate autologous lymphocytes

D. Taramelli, S. Andreola, G. Parmiani, 1984, International journal of cancer.

Cancer procoagulant in human tumor cells: evidence from melanoma patients.

A. Falanga, C. Gambacorti-Passerini, N. Semeraro, 1986, Cancer research.

Human allogeneic melanoma‐reactive T‐helper lymphocyte clones: Functional analysis of lymphocyte‐melanoma interactions

G. Ferrara, M. Herlyn, M. Herlyn, 1991, International journal of cancer.

High incidence of chromosomal lesions involving C-heterochromatin in four human melanoma lines

L. Larizza, M. Rodolfo, G. Fossati, 1989, Clinical & Experimental Metastasis.

Cancer patients' lymphocytes contain CD3+CD4+cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cells

S. Andreola, M. Quaia, E. Galligioni, 2005, Cancer Immunology, Immunotherapy.

Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I)iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays.

R. Herberman, G. Fossati, H. Holden, 1975, Cancer research.

CANCER PROCOAGULANT AND HAEMOSTATIC ANBORMALITIES IN MELANOMA

N. Semeraro, M. Donati, S. Gordon, 1986, The Lancet.

Cellular immunity to human breast carcinoma

U. Veronesi, S. Canevari, G. Fossati, 1972, International journal of cancer.

Antibody Binding to Membrane of Cultured Melanoma Cells by Sera of Melanoma Patients 1

S. Canevari, P. Vezzoni, G. Fossati, 1979, Tumori.

Humoral cytotoxicity in melanoma patients and its correlation with the extent and course of the disease

S. Canevari, G. Fossati, G. Della Porta, 1975, International journal of cancer.

Lymphocyte toxicity test in clinical melanoma.

N. Cascinelli, U. Veronesi, S. Canevari, 1973, European journal of cancer.

Complement - dependent Serum Cytotoxicity of Cancer Patients Studied by 51Cr Release Assay on Human Cancer Lines 1

S. Canevari, P. Vezzoni, G. Fossati, 1977, Tumori.

Methods for the Study of Cell-Mediated Immunological Response against Human Tumor Cells Cultured in Vitro

M. Colnaghi, G. Fossati, 1970, Tumori.

Delayed cutaneous hypersensitivity reaction to crude and semi-purified tumor extracts in cancer patients

S. Canevari, C. Grandi, S. Miotti, 1981, Cancer Immunology, Immunotherapy.

The undefined relationship between tumor antigens and histocompatibility antigens on cancer cells

G. Parmiani, G. Fossati, G. Porta, 1980, La Ricerca in clinica e in laboratorio.

Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes

D. Taramelli, G. Parmiani, M. Sensi, 2004, Cancer Immunology, Immunotherapy.

Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung

D. Taramelli, N. Cascinelli, G. Parmiani, 2004, Cancer Immunology, Immunotherapy.

Allostimulation-induced tumor cytotoxic cells: from mouse to man.

G. Parmiani, M. Sensi, G. Fossati, 1985, Immunology today.

Immunochemical analysis of the determinant recognized by a monoclonal antibody (MBr1) which specifically binds to human mammary epithelial cells.

S. Canevari, S. Sonnino, A. Balsari, 1983, Cancer research.

Enzymatic and immunological identification of a cysteine proteinase procoagulant in human melanoma

A. Falanga, N. Semeraro, M. Donati, 1986 .

Chromosome abnormalities and fragile sites in human melanoma.

G. Sozzi, M. Pierotti, M. Miozzo, 1990, Cancer genetics and cytogenetics.

Delayed Cutaneous Hypersensitivity Reaction to Carcinoembryonic Antigen in Cancer Patients

G. Bonfanti, G. Fossati, S. Orefice, 1982, Tumori.

Immune responses to tumour and embryo cells in patients with mammary carcinoma.

S. Canevari, G. Fossati, G. Della Porta, 1973, The British journal of cancer. Supplement.

Cellular immunity in cancer patients against embryonal cells.

S. Canevari, G. Fossati, G. Della Porta, 1973, Journal of the National Cancer Institute.

Cellular immune reaction to human malignant melanoma and breast carcinoma cells.

S. Canevari, G. Fossati, G. Della Porta, 1976, Journal of the National Cancer Institute.

PHENOTYPIC HETEROGENEITY OF HLA PRODUCTS ON HUMAN MELANOMA CELLS

D. Taramelli, N. Cascinelli, S. Andreola, 1986, Journal of immunogenetics.

Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones

A. Anichini, G. Parmiani, G. Fossati, 1986, The Journal of experimental medicine.

Infusion of Autologous Alloactivated Lymphocytes in Melanoma Patients: Toxicity and Immunologic Monitoring

C. Gambacorti-Passerini, G. Fossati, G. Tona, 1986, Tumori.

Inhibition of Human Melanoma Growth in Nude Mice by Autologous, Alloactivated Peripheral Blood Lymphocytes

D. Taramelli, G. Parmiani, A. Balsari, 1984, Tumori.

Tumorigenicity and dissemination of primary and metastatic human melanomas implanted into different sites in athymic nude mice.

G. Parmiani, M. Rodolfo, A. Balsari, 1988, Invasion & metastasis.

Human renal antigen defined by a murine monoclonal antibody.

S. Ménard, S. Canevari, E. Tagliabue, 1984, Journal of the National Cancer Institute.

C-heterochromatin variation and transposition in tumor progression.

L. Larizza, G. Fossati, E. Ginelli, 1988, Advances in experimental medicine and biology.

Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.

A. Anichini, G. Fossati, G. Parmiani, 1988, Journal of immunology.